- Home
- BOLD vs SNYR Comparison
BOLD vs SNYR Comparison
Compare BOLD & SNYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLD
- SNYR
- Stock Information
- Founded
- BOLD 2018
- SNYR 2010
- Country
- BOLD United States
- SNYR United States
- Employees
- BOLD N/A
- SNYR N/A
- Industry
- BOLD
- SNYR
- Sector
- BOLD
- SNYR
- Exchange
- BOLD Nasdaq
- SNYR NYSE
- Market Cap
- BOLD 49.5M
- SNYR N/A
- IPO Year
- BOLD 2024
- SNYR N/A
- Fundamental
- Price
- BOLD $1.45
- SNYR $2.58
- Analyst Decision
- BOLD Buy
- SNYR Strong Buy
- Analyst Count
- BOLD 3
- SNYR 1
- Target Price
- BOLD $22.50
- SNYR $10.00
- AVG Volume (30 Days)
- BOLD 85.1K
- SNYR 16.3K
- Earning Date
- BOLD 03-27-2025
- SNYR 05-24-2025
- Dividend Yield
- BOLD N/A
- SNYR N/A
- EPS Growth
- BOLD N/A
- SNYR N/A
- EPS
- BOLD N/A
- SNYR 0.28
- Revenue
- BOLD N/A
- SNYR $34,834,243.00
- Revenue This Year
- BOLD N/A
- SNYR N/A
- Revenue Next Year
- BOLD N/A
- SNYR $15.97
- P/E Ratio
- BOLD N/A
- SNYR $9.20
- Revenue Growth
- BOLD N/A
- SNYR N/A
- 52 Week Low
- BOLD $1.42
- SNYR $1.95
- 52 Week High
- BOLD $14.18
- SNYR $10.00
- Technical
- Relative Strength Index (RSI)
- BOLD N/A
- SNYR N/A
- Support Level
- BOLD N/A
- SNYR N/A
- Resistance Level
- BOLD N/A
- SNYR N/A
- Average True Range (ATR)
- BOLD 0.00
- SNYR 0.00
- MACD
- BOLD 0.00
- SNYR 0.00
- Stochastic Oscillator
- BOLD 0.00
- SNYR 0.00
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.